CoreAge Rx advertises sermorelin from $99 per month. Hone’s public page lists $175 per month for medication and separately describes membership and test charges. Those figures are not directly comparable all-in totals.
This is a comparison of public service information, not a clinical trial of the two providers. CoreAge Rx receives featured commercial placement on this site. We identify the practical differences and missing details without claiming that either company’s preparation is clinically superior.
A visible medication starting rate versus a broader testing-and-membership structure. Compare the complete service you would actually purchase.
Read the price structure before comparing the number
Ask Hone which membership is required and which consultation and testing services are included. Ask CoreAge Rx which tests and follow-ups are covered by the selected plan. Build a three-month total rather than adding only the medication price.
A rate per month, a vial price, and an introductory reduction can describe different commitments. Save the final terms for the selected product and compare the same period of care. Our cost guide provides a consistent checklist.
Compare the assessment and follow-up
Hone places more public emphasis on biomarker testing and a broader health program. That may be useful if those services fit the clinical question, but a larger panel does not itself establish better care. Ask what each test can answer and how it will change the treatment decision.
Ask who provides the clinical decision, whether additional testing is needed, how questions reach the clinician, and what a refill involves. For remote care, confirm the clinician can treat a patient in your physical location.
Identify the actual medicine
For both providers, request the pharmacy, full ingredient list, concentration, quantity, route, and beyond-use date. Do not assume the products are identical because both pages use the word sermorelin. Additional ingredients or a route change create a different comparison.
Compounded drugs are not FDA-approved. Historical GEREF approval does not approve current compounds, and facility registration does not establish finished-product approval. The pharmacy guide explains how to verify the entities and information involved.
Separate the service choice from the medical choice
A convenient care model and a clear price can make a service easier to use. They do not establish that sermorelin is appropriate for the reason you are seeking help. Ask the clinician which diagnosis or concern is being addressed and what evidence applies to the intended outcome.
The current literature does not let this review rank these platforms by clinical effectiveness. A hormonal response, customer testimonial, or provider research page is not a direct head-to-head comparison of their dispensed preparations.
Questions to bring to both services
What is the total charge and term? Which pharmacy fills this order? What tests and follow-ups are included? How do I obtain help with a reaction or product question? What happens if the clinician does not prescribe or later recommends stopping?
Read the full CoreAge Rx review and Hone Health review for source-specific details. Use the first-visit checklist to compare the answers. A disclosed featured placement can direct attention to a service; it should not determine your personal clinical decision.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.
- Hone Health: Sermorelin InjectionsProvider primary source · Medication and membership figures are displayed separately.
- HHS: Telehealth licensing across state linesUS government guidance · Licensure options depend on the patient location and state rules.
- FDA: Risks of compounded drugsUS regulator · Explains lack of FDA approval and the risks of poor-quality compounded preparations.
- FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
- FDA: 2013 GEREF withdrawal determinationFederal Register / FDA · Historical GEREF products were not withdrawn for safety or effectiveness reasons; this does not approve current compounds.
- Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
- Endotext: Growth Hormone and AgingExpert clinical evidence review · Separates hormone and body-composition findings from functional outcomes and long-term unknowns.